Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia
Huimin Zhang, Jindi Huang, Rui Chen, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 72, pp. 116994-116994
Closed Access | Times Cited: 16

Showing 16 citing articles:

HiGNN: A Hierarchical Informative Graph Neural Network for Molecular Property Prediction Equipped with Feature-Wise Attention
Weimin Zhu, Yi Zhang, Duancheng Zhao, et al.
Journal of Chemical Information and Modeling (2022) Vol. 63, Iss. 1, pp. 43-55
Closed Access | Times Cited: 41
DEEPCYPs: A deep learning platform for enhanced cytochrome P450 activity prediction
Daiqiao Ai, Hanxuan Cai, Jiajia Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Design, synthesis and biological evaluation of dual CDK9/PARP inhibitors for the treatment of cancer
Jindi Huang, Ya He, Sumeng Chen, et al.
European Journal of Medicinal Chemistry (2025), pp. 117367-117367
Closed Access
Exploring the cytotoxic effect and CDK-9 inhibition potential of novel sulfaguanidine-based azopyrazolidine-3,5-diones and 3,5-diaminoazopyrazoles
Ebtehal M. Husseiny, Hamada S. Abulkhair, Nehad M. El‐Dydamony, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106397-106397
Closed Access | Times Cited: 16
Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease
Rui Chen, Xinjuan Li, Hongsong Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115253-115253
Closed Access | Times Cited: 14
Multiscale adaptive and attention-dilated convolutional neural network for efficient leukemia detection model with multiscale trans-res-Unet3+ -based segmentation network
K Gokulkannan, T A Mohanaprakash, J. DafniRose, et al.
Biomedical Signal Processing and Control (2024) Vol. 90, pp. 105847-105847
Closed Access | Times Cited: 5
Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges
Alessia Mondello, Michele Dal Bo, Giuseppe Toffoli, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Artificial intelligence for small molecule anticancer drug discovery
Lihui Duo, Yu Liu, Jianfeng Ren, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 933-948
Closed Access | Times Cited: 3
Orally Administered Drugs and Their Complicated Relationship with Our Gastrointestinal Tract
Stavros Bashiardes, Christina Christodoulou
Microorganisms (2024) Vol. 12, Iss. 2, pp. 242-242
Open Access | Times Cited: 2
Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations
Pooja Singh, Vikas Kumar, Tae Sung Jung, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 8
Closed Access | Times Cited: 1
Identification of thrombopoiesis inducer based on a hybrid deep neural network model
Qi Mo, Ting Zhang, Jianming Wu, et al.
Thrombosis Research (2023) Vol. 226, pp. 36-50
Closed Access | Times Cited: 3
VDDB: A comprehensive resource and machine learning tool for antiviral drug discovery
Shunming Tao, Yihao Chen, Jingxing Wu, et al.
MedComm – Future Medicine (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Meta Learning with Attention Based FP-GNNs for Few-Shot Molecular Property Prediction
Xiaoliang Qian, Bin Ju, Ping Shen, et al.
ACS Omega (2024) Vol. 9, Iss. 22, pp. 23940-23948
Open Access
SOGCN: Prediction of key properties of MR-TADF materials using graph convolutional neural networks
Y. Li, Bohua Zhang, Ai‐Min Ren, et al.
Chemical Engineering Journal (2024) Vol. 501, pp. 157676-157676
Closed Access
Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework
Zuokun Lu, Jia-Yuan Han, Y. Y. Ji, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40345-e40345
Open Access
Application of graph theory in liver research: A review
Xin Hu, Longyu Sun, Rencheng Zheng, et al.
Portal hypertension & cirrhosis (2024)
Open Access
AI's role in pharmaceuticals: Assisting drug design from protein interactions to drug development
Solene Bechelli, Jérôme Delhommelle
Artificial Intelligence Chemistry (2023) Vol. 2, Iss. 1, pp. 100038-100038
Open Access | Times Cited: 1
Page 1

Scroll to top